Our CEO Lexi Rovner will be speaking on a panel at the State of Cell and Gene Therapy virtual conference today, hosted by Genetic Engineering & Biotechnology News. 🧬 The panel will be moderated by Jonathan D. Grinstein, PhD. Tune in below: https://lnkd.in/eUd6CUmd

The 64x Bio team is in San Francisco for the J.P. Morgan 42nd Annual Healthcare Conference, and is excited to connect with partners, colleagues, and friends!   If you're in San Francisco for the conference, we're looking forward to discussing our latest progress, our plans for 2024, and exploring new partnership opportunities. Reach out to us at [email protected].   The following members of our team are attending:   Lexi Rovner, CEO & Co-founder Farhad (Seyyedhassan) Paylakhi, VP of R&D & Co-founder   We're looking forward to seeing you here!